NUR 213 Exam 2026 – 50+ Verified Questions with Answers | Stroke, Seizures, Parkinson’s, Alzheimer’s, Glaucoma

This expertly verified study resource contains 50+ high-yield multiple-choice questions and correct answers tailored for NUR 213 Exam 2026. It is designed to help nursing students master essential concepts in neurological and pharmacological nursing care, with a strong focus on cerebrovascular and neurodegenerative disorders. The material aligns with standard nursing textbooks such as “Pharmacology and the Nursing Process” by Lilley, Collins, and Snyder, offering a solid foundation for academic and clinical success. Topics covered include: Normal and abnormal cerebrospinal fluid (CSF) findings, including meningitis indicators Stroke risk factors, especially non-modifiable ones like age and genetics Antiepileptic drugs and treatment protocols for seizures, including status epilepticus Parkinson’s disease treatments (e.g., Rasagiline, Requip, Amantadine, Selegiline) Alzheimer’s pharmacologic management using cholinesterase inhibitors and NMDA blockers (e.g., Aricept, Namenda) Commonly prescribed eye medications for acute injuries and glaucoma (e.g., timolol, pilocarpine, latanoprost) This resource is highly relevant for students in: BSN (Bachelor of Science in Nursing) RN-to-BSN bridge programs Accelerated nursing programs Pharmacology and pathophysiology courses It also supports NCLEX-RN preparation by reinforcing critical knowledge areas related to neuro and sensory disorders, medication actions, and patient care priorities. The document is presented in a clear Q&A format with bolded answers, facilitating focused and efficient review. Keywords: NUR 213, stroke risk factors, cerebrospinal fluid, meningitis, seizures, epilepsy drugs, status epilepticus treatment, Parkinson’s medications, Alzheimer’s treatment, cholinesterase inhibitors, Namenda, glaucoma treatment, timolol, pilocarpine, latanoprost, pharmacology nursing, NCLEX prep, BSN, RN-to-BSN, nursing exam review